PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 8

被引：41

作者：

Aquilante, Christina L. ^{[1
]}

Niemi, Mikko ^{[4
]}

Gong, Li ^{[2
]}

Altman, Russ B. ^{[2
,3
]}

Klein, Teri E. ^{[2
]}

机构：

[1] Univ Colorado, Dept Pharmaceut Sci, Skaggs Sch Pharm & Pharmaceut Sci, Aurora, CO USA

[2] Stanford Univ, Dept Genet, Palo Alto, CA 94304 USA

[3] Stanford Univ, Dept Bioengn, Palo Alto, CA 94304 USA

[4] Univ Helsinki, Dept Clin Pharmacol, HUSLAB, Helsinki Univ Cent Hosp, SF-00250 Helsinki, Finland

来源：

PHARMACOGENETICS AND GENOMICS | 2013年 / 23卷 / 12期

关键词：

CYP2C8; CYP2C8*3; metabolism; pharmacogenetics; pharmacogenomics; pharmGKB;

D O I：

10.1097/FPC.0b013e3283653b27

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

[No abstract available]

引用

页码：721 / 728

页数：8

共 151 条

[1]

Agúndez JAG, 2009, EXPERT OPIN DRUG MET, V5, P607, DOI [10.1517/17425250902970998 , 10.1517/17425250902970998]

[2] A single-nucleotide polymorphism tagging set for human drug metabolism and transport [J].

Ahmadi, KR ;

Weale, ME ;

Xue, ZYY ;

Soranzo, N ;

Yarnall, DP ;

Briley, JD ;

Maruyama, Y ;

Kobayashi, M ;

Wood, NW ;

Spurr, NK ;

Burns, DK ;

Roses, AD ;

Saunders, AM ;

Goldstein, DB .

NATURE GENETICS, 2005, 37 (01) :84-89

[3] Impact of the CYP2C8*3 polymorphism on the drug-drug interaction between gemfibrozil and pioglitazone [J].

Aquilante, Christina L. ;

Kosmiski, Lisa A. ;

Bourne, David W. A. ;

Bushman, Lane R. ;

Daily, Elizabeth B. ;

Hammond, Kyle P. ;

Hopley, Charles W. ;

Kadam, Rajendra S. ;

Kanack, Alexander T. ;

Kompella, Uday B. ;

Le, Merry ;

Predhomme, Julie A. ;

Rower, Joseph E. ;

Sidhom, Maha S. .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 75 (01) :217-226

[4]

Aquilante Christina L., 2008, Human Genomics, V3, P7

[5]

Aquilante CL, 2013, PHARMACOTHERAPY

[6] Cytochrome P4502C8 and flavin-containing monooxygenases are involved in the metabolism of tazarotenic acid in humans [J].

Attar, M ;

Dong, D ;

Ling, KHJ ;

Tang-Liu, DDS .

DRUG METABOLISM AND DISPOSITION, 2003, 31 (04) :476-481

[7] Gemfibrozil greatly increases plasma concentrations of cerivastatin [J].

Backman, JT ;

Kyrklund, C ;

Neuvonen, M ;

Neuvonen, PJ .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 72 (06) :685-691

[8] Benzylic Oxidation of Gemfibrozil-1-O-β-Glucuronide by P450 2C8 Leads to Heme Alkylation and Irreversible Inhibition [J].

Baer, Brian R. ;

DeLisle, Robert Kirk ;

Allen, Andrew .

CHEMICAL RESEARCH IN TOXICOLOGY, 2009, 22 (07) :1298-1309

[9] CYP2C8 polymorphisms in Caucasians and their relationship with paclitaxel 6α-hydroxylase activity in human liver microsomes [J].

Bahadur, N ;

Leathart, JBS ;

Mutch, E ;

Steimel-Crespi, D ;

Dunn, SA ;

Gilissen, R ;

Van Houdt, J ;

Hendrickx, J ;

Mannens, G ;

Bohets, H ;

Williams, FM ;

Armstrong, M ;

Crespi, CL ;

Daly, AK .

BIOCHEMICAL PHARMACOLOGY, 2002, 64 (11) :1579-1589

[10]

Baldwin SJ, 1999, BRIT J CLIN PHARMACO, V48, P424

← 1 2 3 4 5 6 7 8 9 10 →